Tumid lupus erythematosus at the site of a scar

Archives of Dermatology

Volumn 145, Issue 3, 2009, Pages 343-344

  Nousari, Carlos H ^a   Perez, Gregory ^a   Kowalczyk, John P ^a   Montie, Dwayne ^a  

^a Ste 101 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROXYCHLOROQUINE; PREDNISONE;

ADULT; CASE REPORT; CD4 CD8 RATIO; CLINICAL FEATURE; DRUG DOSE REDUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; LUPUS ERYTHEMATOSUS; NOTE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN SCAR; TUMID LUPUS ERYTHEMATOSUS;

ADULT; CICATRIX; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; SKIN;

EID: 62649127978     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.615     Document Type: Note

References (5)

1. Kuhn A, Sonntag M, Ruzicka T, Lehmann P, Megahed M. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J Am Acad Dermatol. 2003;48(6):901-908.
2. Alexiades-Armenakas MR, Baldassano M, Bince B, et al. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum. 2003;49(4):494-500.
3. Ruiz H, Sanchez JL. Tumid lupus erythematosus. Am J Dermatopathol. 1999;21(4):356-360.
4. Ueki H. Köbner phenomenon in lupus erythematosus [in German]. Hautarzt. 1994;45(3):154-160.
5. Mutasim DF, Adams BB. Immunofluorescence in dermatology. J Am Acad Dermatol. 2001;45(6):803-822.